Inphi shares take beating on lower profits
Wall Street punished Inphi Corp. on July 27, pushing down shares 20 percent after the company reported lower-than-expected earnings and gave a gloomier financial forecast than analysts had predicted.
New CalAmp CEO walks in as focus shifts
CalAmp is back. The Oxnard-based firm, which trades on the Nasdaq and has a 98,0000-square-foot facility in the Tri-Counties, had a brush with death when it temporarily lost a huge customer and revenues halved. But analysts say the company’s turnaround team has righted the ship and handed off power to a new CEO.
Calavo bags fresh food firm for $96M
Calavo Growers’ $96 million purchase of a fast-growing fresh food company signals that it’s come a long way since its homegrown roots as an avocado cooperative.
Beyond biologics: Amgen bets new drugs will pay dividend
Amgen executives believe the biotech giant will grow substantially in the next decade, pursuing drugs that treat major melanoma and bone loss.
ValueClick defies its skeptics
ValueClick is out to prove to investors that it still has some pluck after more than a decade in the digital marketing business.
Bank earnings rebound signals better times
Santa Barbara Bank & Trust and its smaller banking peers in the region are reporting improved earnings.
